Ergoresearch announces first quarter 2010 financial results

Ergoresearch Ltd (TSX VENTURE:ERG) -

- Annual sales increased by 160% to $1 596 107 compared to $612 127 for the same period last year.

- Net profits before income tax of $187 169 representing an increase of 199% from $62 590 for the same period last year.

- Cash flow from operating activities significantly increased from $8 491 for the same period last year to $292 404 for the first quarter of 2010.

- Revenues for the past twelve months totalled $6 292 688 and net earnings for the same period totalled $835 289

All amounts in Canadian dollars unless otherwise stated.

Ergoresearch ltd ("Ergoresearch" or the "Company") announced today its results for the first quarter of 2010 ended September 30, 2009. During the year, Ergoresearch recorded unprecedented sales and a strong growth in net earnings and cash generated from operating activities.

During the first quarter ended September 30, 2009, the Company's sales reached $1 569 107, representing a 160% increase compared to the 2008 results then at $612 127. Net earnings before income taxes almost tripled from $62 590 for the same period last year to $187 169 this quarter.

Before the change in operating working capital, cash flow from operating activities significantly increased to $292 404 for the first quarter of 2010 compared to a $8 491 for the same period last year.

"We are satisfied with the results of this first quarter of 2010. Notwithstanding challenging economic times, the Company very successfully integrated its most recent acquisition while reaping the benefits of a strong internal growth in its other divisions. The first quarter will also mark history as the Company recorded yet another increase of its net profits not to mention generating positive cash flow from its operations and a strong growth in revenues.

"Such noteworthy improvements stand witness to the hard work of our employees, management team and Directors. All have rallied around a common strategy and provided their best efforts to allow the Company to reach summiting performances" stated Sylvain Boucher, President and CEO of Ergoresearch Ltd.

Source: Ergoresearch Ltd

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.